14 02, 2018

New Research: Growth Hormone Biomarker

By | February 14th, 2018|Categories: Blog|Tags: , , , , , , , , , , , , , , |0 Comments

A new paper, published by the team led by Dr. David Cowan at the WADA-Accredited Drug Control Centre at King’s College London, has been published in “Rapid Communications in Mass Spectrometry.” The research focuses on the usage of P-III-NP as a [...]

13 02, 2018

PCC Funding: Not Just for WADA Labs

By | February 13th, 2018|Categories: Blog|Tags: , , , , , , , , , , , , , , , , |0 Comments

A common misconception about anti-doping science is that practitioners of research in this field are all associated with anti-doping laboratories. In fact, the majority of investigators we fund represent numerous fields of science (from analytical chemistry to physiology), and conduct their [...]

14 12, 2016

Research Update: Dr. Cowan

By | December 14th, 2016|Categories: Blog|Tags: , , , , , , , , , , , , , , , , , , , |0 Comments

  Dr. Cowan, Head of the WADA-Accredited Drug Control Center at King's College London, has provided the following update on his PCC funded research. Project title: Developing a mass spectrometric method for PIIINP and other collagen bone biomarkers to detect rHGH [...]

Load More Posts